Two small cell lung cancer (SCLC) cell lines were established from pericardia! and pleura! effusions of a patient with histopathologically proven SCLC of the oat cell type. Chemotherapy was administered without response during the 148-day period prior to the establishment of the first cell line, SCLC-22H, and some of the same drugs were admin istered in the 15 days prior to the establishment of the second cell line, SCLC-21H. Both cell lines differed markedly in their biochemical, kinetic, and morphological properties. Although the biomarkers i -Dopa decarboxylase, bombesin, carcinoembryonic antigen, and neurotensin were detectable in SCLC-22H, they were undetectable or low in SCLC-21H. The population doubling time was twice as fast and the colony forming efficiency higher in S( IX -2111 than in SCLC-22H. They both expressed high concentrations of the SCLC marker enzymes neuronspecific enolase and the creatine kinase isoenzyme BB and showed no significant differences in their chromosomal characteristics, c-myc was amplified and expressed in both cell lines, and SCLC-21H had an additional rearrangedand amplified EcoKl c-myc fragment. Morpholog ical differences were apparent in liquid culture, cytology, and xenograft histology, SCLC-21H grew much more loosely than SCLC-22H, and had more prominentnucleoli and more abundantcytoplasm. Ultrastructurally dense core granules were present in both cell lines. SCLC-21H thus expressed properties of the variant cell type of SCLC, whereas SCLC-22H had mixed classic/variant features. An in viro progression of the patient's tumor from a pure small cell to a mixed small cell/large cell morphology could be demonstrated, which suggests that cell line SCLC-22H represents a cell type characteristic for the transitional phase of the tumor. The features of this cell line therefore define a new subclass of SCLC called transitional cell type. SCLC-22H may be of use to study the mechanisms involved in the classic to variant transition, which probably has a considerable impact on the prognosis and response to therapy.
INTRODUCTION
Recent in vitro studies performed on 50 permanent human SCLC3 cell lines established at the National Cancer Intitule, Bethesda, MD by Carney et al.(l) and Gazdar et al. (2) resulted in a subclassification of SCLC into classic and variant cell types based on the expression of neuroendocrine properties. The authors found that the majority of their cell lines (70%) had high activities of DDC (3) and elevated levels of bombesin (4) , both features of cells of the neuroendocrine system (5, 6) , in addition to typical morphological characteristics of the inter mediate cell type of SCLC (7) . Cell lines with these features were termed classic SCLC cell lines. The remaining cell lines Received 1/4/86; revised 9/26/86, 12/31/86; accepted 1/7/87. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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(30%), however, lacked DDC and bombesin, and 10 of 15 of these cell lines had a more large cell-like morphology; these were termed variant SCLC cell lines.
Further studies revealed additional differences between both subclasses of SCLC: (a) classic cell lines had higher levels of NSE than variant cell lines (8) and detectable levels of neuro tensin (9) and CEA (10); (b) the PDT in liquid culture and the latent period of nude mouse xenografts were shorter and the colony forming efficiency in soft agarose higher for variant cell lines than those for classic cell lines; (c) variant cell lines had a more than 5-fold amplification of the c-myc protooncogene; whereas classic cell lines, with one exception, were not amplified (2, 11) ; (d) variant cell lines were resistant to radiotherapy but sensitive to treatment with interferon (12, 13) ; and (e) classic cell lines had single or clustered dense core granules on electron microscopy and only 2 of 6 variant cell lines had single dense core granules (1) . Both SCLC subclasses, however, had equal amounts of CK-BB (14) and a chromosomal 3p deletion (15) , which clearly distinguished them from non-SCLC. A summary of the respective properties is given in Table 1 .
At the time of diagnosis approximately 6-18% of patients with SCLC have a mixed small cell/large cell morphology (16, 17) . This tumor type is comparable to pure SCLC with respect to age and sex distribution, tumor spread, and sites of mÃ©tas tases at the time of diagnosis. However, patients with mixed small cell/large cell tumors have a considerably worse prognosis and lower treatment response rate than those with pure SCLC (18) . Variant SCLC cell lines are believed to be the in vitro correlate of the mixed in vivo small cell/large cell tumors. The original tumor histology of the patients from whom the 50 SCLC cell lines were derived revealed in 5 cases a mixed small cell/large cell morphology (2) . Cell lines established from these patients belonged to the variant subclass of SCLC with large cell-like morphology. The remaining 10 variant cell lines (5 had large cell-like morphology) were derived from patients with pure small cell tumors. Three of these cell lines belonged to the classic subclass during early in vitro cultivation and converted to the variant type after prolonged cultivation or xenotransplantation (one with large cell-like morphology). The remaining 4 cell lines with biochemical and morphological characteristics of the variant SCLC subclass derived from patients with pure small cell tumors could have been a result of clonal selection during early cultivation.
Amplification and expression of the c-myc protooncogene was with one exception (NCI-N231) exclusively found in var iant SCLC cell lines with large cell-like morphology (8 of 11) . This was in contrast to the amplification and expression of N- (19) and L-myc (20) and suggested that c-myc might be respon sible for the altered morphology of this SCLC subclass. In a most recent study, Johnson et al. (21) showed that a cell line with classic features altered its morphology and growth prop erties but not its biochemical characteristics into those of the variant subclass upon transfection and expression of c-myc.
Although ample evidence has been provided for the presence of at least 2 SCLC subclasses, classic and variant with and (Fig. IA) , and tumor mÃ©tastases were found in the liver and bone marrow. The first chemo therapy cycle consisted of iphosphamide, etoposide, and vindesine and the second of cw-platinum, doxorubicin, and vincristine. Because of a tumor progression on chest X-ray, the following 3 cycles contained cyclophosphamide, etoposide, and vindesine, and the tumor remained stationary on chest X-ray and abdominal ultrasound. Additional staging procedures, however, revealed by bone scan a novel developed skeletal tumor involvement. As a result cyclophosphamide, doxorubicin, and vincristine were administered at the sixth cycle but the tumor kept progressing. On February 25, 1982, a pericardia! effusion was tapped, and the tumor cytology showed typical small cell elements interspersed with larger cells which had more cytoplasm and prominent nucleoli (Fig. \B) . This specimen gave rise to cell line SCLC-22H. The patient received a last treatment with cyclophosphamide, doxorubicin, and vincristine. Fifteen days later, on March 12, 1982, a left sided pleural effusion was punctured which contained an abundance of even larger cells and fewer typical small cell elements (Fig. 1C) than the previous specimen. Cell line SCLC-21H was established from this effusion. The patient died on March 18, 1982 , and histolÃ³gica! specimens obtained from the right middle lobe of the lung (Fig. ID) , the pericardium (Fig.  1Â£) ,and the liver (Fig. IF) revealed a typical mixture of small and large cell-like elements with a dominance of the latter and no apparent proportional differences in the individual specimens.
Both cell lines, SCLC-22H and SCLC-21H, were established and maintained in RIO medium (GIBCO Europe, Paisly, United Kingdom) as described elsewhere (22) . They grow as floating cell aggregates, are split once or twice a week, express human isoenyzmes, and are free of Mycoplasma contamination as tested by the Institute for Microbiology, Marburg, West Germany.
Morphological Examinations. Tumor tissue obtained by biopsy, au topsy, and from nude mouse xenografts was fixed in 4% v/v formalde hyde containing PBS, embedded in paraffin, and stained with hematoxylin and eosin. Liquid specimens, i.e., cavity effusions and cell lines, were cytocentrifuged immediately, fixed in 70% v/v ethanol, and stained with hemotoxylin and eosin. Electron microscopical examination of cell lines and nude mouse xenografts was performed by fixation in a formaldehyde-glutaraldehyde-picric acid fixative (23) , postfixation in OsO4, embedding in Epon, and staining with uranyl acetate-lead citrate.
Growth Studies. Kinetics in liquid culture were done in RIO medium as previously described (22), results plotted on a semilogarithmic scale, and the PDT calculated from the slope of the growth curve during logarithmic growth phase. Cloning of the cell lines in a 0.3% agarosecontaining top layer over a 0.5% agarose-containing base layer in RIO medium and s.c. xenotransplantation into NMRI athymic nude mice (nu/nu) were performed as earlier published (22) .
Biomarker Evaluations. Activities and concentrations of the enzymatical markers DDC, NSE, CK, and CK-BB and concentrations of CEA were determined in homogenates of approximately IO7 cells in logarithmic growth phase as published (10) . Radioimmunoassay kits and enzyme immunoassay kits were obtained from Pharmacia, Uppsala, Sweden for NSE, from Institut National des Radioelements, Fleurus, Belgium for CK-BB, and from Abbott, Irving, TX for CEA. Protein concentrations were measured by means of a Coomassie Brilliant Blue binding protein assay (Bio-Rad, Munich, West Germany).
The concentrations of the 14-amino acid amphibian peptide bombesin and the 13-amino acid neuroendocrine peptide neurotensin were evaluated in acetic cell extracts. Cells collected in logarithmic growth phase were washed twice in PBS, made sheer in 2 M acetic acid, boiled in a water bath for 10 min, and centrifuged at 10,000 x g and 4Â°Cfor 15 min. Supernatants were lyophilized and dissolved in PBS supple mented with 0.25% w/v bovine serum albumin. Commercial polyclonal double antibody radioimmunoassays were applied as described by the manufacturer (Inumino Nuclear Corporation, Stillwater, MN) and protein concentrations were determined according to the method of Lowry et al. (24) . The radioimmunoassay for bombesin cross-reacts with the mammalian bombesin analogue gastrin releasing peptide, a 27-amino acid neuroendocrine peptide with comparable biological ac tivities. The detection limits were 50 fmol bombesin and 10 fmol neurotensin/ml, respectively.
Cytogenetic Analyses. To examine the cell lines for modal chromo some numbers, chromosomal aberrations, and the presence of HSRs and DMs, metaphase chromosome spreads were prepared by a modified version of the method described by Jaeger and Kuhn-Schlage (25) as follows. Cell aggregates were disrupted by trituration and the culture medium replaced by fresh medium containing 15 lU/ml heparin (Hoff mann-La Roche, Grenzach-Wyhlen, West Germany). Two h later 5 ng/ ml ethidium bromide (Serva, Heidelberg, West Germany) were added, incubated for 1.5 h, and then 40 ng/ml Colcemid (GIBCO) were added followed by an additional 30-min incubation period at 37Â°C. Mitoses were collected, chromosome spreads prepared, and G-banding per formed by the trypsin-Giemsa technique (26) . For each cell line 50 metaphases were evaluated for chromsome numbers and 9-10 for chromosomal aberrations.
DNA and RNA Analyses. Cell lines were harvested during log growth phase and DNA and RNA prepared by the methods of Hieter et al. (27) and Chirgwin et al. (28) , respectively. Ten ng of DNA from different SCLC cell lines were digested with EcoRI and Southern blots prepared (29) . Ten Â¿Â¿g of total RNA were electrophoresed in 0.8% agarose and Northern blots prepared. Gene probes used for evaluation of the myc family of genes included a Smal-EcoRl fragment for L-myc (20) . an NB-1 fragment for N-myc (30) , and a CYaI-Â£c0RI fragment for the third exon of c-myc (31) . Blots were hybridized to L-, N-, and cmyc probes, washed as reported by Little et al. (11) and Ã'au et al. (19, 20) , and autoradiographed.
RESULTS
Morphological Examinations. The gross morphological ap pearances of both cell lines, SCLC-22H and SCLC-21H, are compared in Fig. 2, A suspended sheets and chains with loose intercellular contacts. On cytological examination SCLC-22H consisted of a mixture of cells with small and large cell-like features (Fig. 2C) , and SCLC-21H almost exclusively exhibited large cells with abun dant cytoplasm and prominent nucleoli (Fig. 2D) . These mor phological differences were more apparent in nude mouse xenografts (Fig. 2, E and F) , with SCLC-22H showing the features of the intermediate cell type of SCLC with some large cell-like elements intermixed, whereas SCLC-21H was predominantly composed of large cell-like elements.
Electron microscopical examinations showed single dense core granules near the cytoplasmic membrane in both cell lines and no ultrastructural differences were found.
Growth Properties and Biomarker Expression. In Fig. 3 the PDTs of cell lines SCLC-22H and SCLC-21H in liquid culture are compared showing a faster growth of cell line SCLC-21H with a PDT of 45 h as compared to 75 h for SCLC-22H. The soft agarose colony formation showed a higher percentage of stem cells for cell line SCLC-21H with a colony forming efficiency of 3.4% as compared to 2.2% for cell line SCLC-22H ( Table 2) .
The biomarker expression of both cell lines is summarized in Table 2 . SCLC-22H expressed moderate to high concentrations of DDC, CEA, bombesin, NSE, neurotensin, CK, and CK-BB, all characteristic biochemical features of the classic SCLC subclass. DDC and CEA concentrations ranged from 80-727 units/mg and 38-62 ng/mg, respectively, and remained stable up until passage 65, the highest evaluated passage. In contrast.
SCLC-21H had absent or low concentrations of DDC, CEA, bombesin, and neurotensin and had lower levels of NSE than did SCLC-22H which defined this cell line from biochemical aspects as a variant SCLC cell line. DDC activities ranged from 0-20 units/mg and CEA levels from <2-6.5 ng/mg up until passage 16. Thereafter, both marker concentrations steadily increased and were 267 units/mg for DDC and 108 ng/mg for CEA at passage 146. CK activities and CK-BB levels were persistently high in both cell lines.
Cytogenetics and Oncogene Analyses. The modal chromo some numbers were 43 for cell line SCLC-22H with a range from 40-47 and 42/43 for cell line SCLC-21H with a range from 39-44 (Fig. 4) . DMs were found in 1 of 50 metaphases and HSRs in 1 of 10 metaphases located on chromosome 2q of cell line SCLC-22H. In contrast, neither DMS nor HSRs were present in cell line SCLC-2 IH. Both cell lines had a deletion 14-23 of the short arm of at least one chromosome 3 as previously described by Whang-Peng et al. (15) . This deletion was found in 4 of 10 metaphases of SCLC-22H and 5 of 9 metaphases of SCLC-2 IH. Common chromosomal abnormal ities indicating a common derivation of both cell lines were (a) marker chromosomes l (SCLC-22H, 8 of 10 metaphases; SCLC-2 IH, 7 of 9 metaphases) and 2 (SCLC-22H, 7 of 10 metaphases; SCLC-2 IH, 9 of 9 metaphases); (b) deletion 6q (SCLC-22H, 10 of 10 metaphases; SCLC-2 IH, 5 of 9 meta phases); (c) aberration 12,1 (SCLC-22H, 8 of 10 metaphases; SCLC-2 IH, 9 of 9 metaphases); and (d) aberration 12,2 (SCLC-22H, 8 of 10 metaphases; SCLC-2 IH, 8 of 9 metaphases). Structural aberrations of chromosomes 1, 2, and 8, which are known to contain the L-, N-, and c-myc genes, respectively (20, (32) (33) (34) , could not be identified. Representative metaphase spreads for both cell lines are depicted in Fig. 5 . Fig. 6 shows the results of DNA and RNA analyses of cell lines SCLC-22H, SCLC-2 IH, and control cell lines with a third exon c-myc probe (31) . Both cell lines were amplified for the 12.7-kilobase germ line EcoRl c-myc fragment at levels com parable to control cell line NCI-N417 (about 50-fold). Cell line SCLC-21H had an additional, rearranged, and amplified c-myc band that was not detectable in other SCLC cell lines studied including SCLC-22H. Ten ng of total cytoplasmic RNA were analyzed by Northern blotting, and a single 2.3-kilobase band, the normal size of the c-myc transcript, was found. The c-myc mRNA levels of cell lines SCLC-22H and SCLC-21H were between those of cell lines NCI-HI46 (relative amount of cmyc mRNA, 6-fold) and cell line NCI-N417 (relative amount of c-myc mRNA, 25-fold). The amount of c-myc mRNA of cell line SCLC-21H appears to be more than the amount of SCLC-22H in the blot shown in Fig. 6 . This result, however, could not be reproduced in 3 additional experiments. Thus the levels of c-myc mRNA in both cell lines are comparable. Other genes of the myc family, i.e., N-and L-myc, were neither amplified nor expressed in both SCLC cell lines.
DISCUSSION
We established 2 SCLC cell lines from specimens of different metastatic sites collected from the same patient within a period of 15 days. Both cell lines (designated SCLC-22H and SCLC-21H) had distinct biochemical, kinetic, and morphological properties ( Table 2) . At diagnosis the patient's tumor revealed pure oat cell morphology, but treatment was unsuccessful. The second tumor specimen obtained (pericardial effusion) showed morphological features of a mixed small cell/large cell tumor and the resulting cell line (SCLC-22H) had morphological features of the classic and variant cell type, biochemical and kinetic features of the classic cell type, and molecular biological features of the variant cell type. The third tumor specimen obtained (pleural effusion) had more obvious small cell/large cell features, and the resulting cell line (SCLC-21H) exhibited all properties of the variant cell type. At autopsy the patient's tumor had converted into a mixed small cell/large cell tumor with a dominance of large cell-like elements in all mÃ©tastases examined.
The presence of a heterogeneous stem cell population in established SCLC cell lines has been demonstrated by Olsson et al. (35) and Spang-Thomsen et al. (36) with regard to differences in nude mouse tumorigenicity, colony forming effi ciency, reactivity with monoclonal antibodies, and radiosensitivity. Other authors, however, did not find any significant differences in the aforementioned properties among subclones of established SCLC cell lines (2, 37) .
Multiple cell lines of SCLC origin established from different metastatic sites also did not differ markedly in their morpho logical appearances (38) , expression of biomarkers, and reactiv ity with monoclonal antibodies (37) . The data presented here are to our knowledge the first describing a difference between SCLC cell lines established from the same patient.
Transitions of classic SCLC cell lines to the variant phenotype after prolonged cultivation (months to years) or xenotransplantation have been published (2, 10, 11, 39) . These changes were observed in 6 cell lines (NCI-H60, NCI-N179, NCI-H289, NCI-N417, OH-1, SCLC-16H) in which all had lost neuroendocrine properties, i.e., DDC activities and dense core granules, and some also had altered their light microscop ical features from a typical small cell to a large cell-like mor phology. The differences between the cell lines described herein almost certainly occurred in vivo, because morphological changes were noted between the pericardial and pleural mÃ©tas tases and because all other differences were detected within the first 25 passages of in vitro culture. The role of cytotoxic drug therapy in the induction of this transition is unknown.
In for either one, or this rearrangement occurred during the time that elapsed between the initiation of both cell lines and thus may be associated with the transition. The rearranged c-myc band is an unlikely candidate to account for the transition, since there is no evidence of transcription. Other genes involved in this rearrangement could, however, be identified and provide a clue for the biological behavior of SCLC. A transition from the classic to the variant subclass of SCLC is accompanied by profound changes in morphology, growth characteristics, partial loss of neuroendocrine properties, and development of radioresistance. These changes may be caused by an increased c-myc expression (21) and may involve one or more intermediate steps as depicted schematically in Fig. 7 . This hypothesis would also explain why most investigators have not been able to demonstrate significant biological differences among subclones initiated from established SCLC cell lines and from different mÃ©tastases (3, 36, 37) , since due to a gradual transition, major differences in the biology of various simulta neously picked stem cells cannot be anticipated.
Recently, Wong et al. (40) demonstrated that c-myc amplifi cation is present in approximately 5% (2 of 45) of SCLC specimens directly obtained from the patients. An association between c-myc amplification and the tumor histology in vivo, however, could not be detected, and all 6 tumors exhibiting the mixed small cell/large cell morphology were not amplified for the c-myc gene. In addition, these authors could demonstrate a homogeneous distribution of c-myc amplification among var ious metastatic sites of patients. These data confirm the relative homogeneity of SCLC postulated in the present paper. phenotype expression outlined in the "Introduction." Literary data, showing a down regulation of c-myc expression upon differentiation induction (41, 42) and a prevention of differen tiation in the case of persistent c-myc expression (43) (44) (45) , agree with the hypothesis expressed in Fig. 7 that a loss of neuroen docrine differentiation may be associated with c-myc overexpression.
To further elucidate the mechanisms involved in the transi tion of SCLC from the classic to the variant cell type, individual cell lines should be cloned to confirm their homogeneity, gene libraries should be prepared to identify differentially expressed genes, and biologically active substances capable of modifying the SCLC phenotype should be found.
